Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-13

Clinical Trial Update: Supplementation of Alpha-linolenic Acid (ALA)-Rich Oil in Humans [EARLY_Phase 1]

View source ↗

Summary

A completed early-stage 1 trial evaluated supplementation with alpha-linolenic acid-rich oil in adults who are overweight or have hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALA-rich oil supplement (alpha-linolenic acid-rich oil)

Snippet

Sponsor: University of Jena | Conditions: Overweight, Hypercholesterolemia | EARLY_Phase 1 | Status: COMPLETED